INOVIO PHARMACEUTICALS, INC. (INO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
ASSETS
Current assets:
Cash and cash equivalents	46.3	71.1	250.7	22.2	23.7	23.8	19.1	57.6
Short-term investments	206.7	330.2	160.9	67.3	57.5	103.6	85.6	105.4
Accounts receivable	11.7	5.5	18.6	2.0	3.3	6.0	15.8	7.3
Prepaid expenses and other current assets	50.1	38.8	40.4	1.6	1.4	2.6	1.7	0.9
Prepaid expenses and other current assets from affiliated entities	0.4	0.3	0.1	1.1	1.1	1.8	1.5
Total current assets	315.2	448.4	471.2	94.2	87.8	138.4	124.6	171.9
Fixed assets, net	7.7	17.5	11.3	12.8	15.9	18.3	9.0	7.3
Intangible assets, net	2.1	2.6	3.1	3.7	4.8	6.0	7.6	3.9
Goodwill	10.5	10.5	10.5	10.5	10.5	10.5	10.5	10.1
Operating lease right-of-use assets	10.2	11.6	12.7	13.8
Other assets	0.7	1.4	26.0	2.7	2.7	2.6	2.1	0.7
Total assets	348.5	495.9	539.8	144.0	131.1	187.2	173.7	213.8

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	79.7	47.6	21.2	18.2	23.1	23.3	19.6	13.1
Accrued clinical trial expenses	10.6	10.3	10.0	4.0	5.7
Operating lease liability	2.8	2.6	2.3	2.1
Grant funding liability	2.5	4.6	7.5	6.1	4.2
Total current liabilities	96.9	65.7	41.7	32.0	35.3	35.4	43.8	31.5
Operating lease liability, net of current portion			18.1	20.4
Deferred tax liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2
Total liabilities	126.2	96.3	78.6	138.5	44.1	44.8	50.3	37.9

Stockholders’ equity:
Common stock	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1
Additional paid-in capital	1,710.7	1,609.6	1,367.4	742.6	707.8	665.8	556.7	534.0
Accumulated deficit	-1,487.8	-1,209.9	-906.2	-739.8	-620.4	-523.4	-434.8	-361.1
Accumulated other comprehensive loss	-0.7	-0.3	-0.3	0.5	-0.5	-0.1	1.3	2.7
Total Inovio Pharmaceuticals, Inc. stockholders’ equity	222.4	399.7	461.1	3.4	86.9	142.4	123.3	175.7
Total liabilities and stockholders’ equity	348.5	495.9	539.8	144.0	131.1	187.2	173.7	213.8